Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
IL-17
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Taltz
(ixekizumab) / Eli Lilly, Japan Tobacco
piclidenoson
(CF101) / Can-Fite
vidofludimus
(IMU-838) / Immunic
